The pharmacokinetics of dapsone after oral administration to healthy volunteers

British Journal of Clinical Pharmacology
F A Pieters, J Zuidema

Abstract

After oral administration of 100 mg dapsone (DDS) to 25 healthy volunteers peak serum DDS concentrations between 1.10 and 2.33 mg l-1 were reached within 0.5 to 4 h. AUCs varied from 20.3 to 75.4 mg l-1 h, while the elimination half-lives ranged from 11.5 to 29.2 h. The apparent volumes of distribution were 0.84 to 1.26 l kg-1 body weight, assuming complete bioavailability. Statistically significant differences in peak drug concentration, peak time and AUC existed between males and females. Absorption and elimination of DDS appeared to be faster than reported in other studies, suggesting differences in DDS kinetics between healthy volunteers and patients.

References

May 17, 1973·Naunyn-Schmiedeberg's Archives of Pharmacology·H Uehleke, S Tabarelli
Dec 1, 1970·The British Journal of Dermatology·J O AlexanderE M Meredith
Mar 1, 1971·Clinical Pharmacology and Therapeutics·R GelberL Levy
Apr 1, 1984·British Journal of Clinical Pharmacology·P A PhilipH J Rogers
Jan 1, 1983·The British Journal of Dermatology·A F SwainL Fry
Jan 1, 1981·Pharmacology·J H PetersR H Gelber
Feb 1, 1980·European Journal of Clinical Pharmacology·R A Ahmad, H J Rogers
Jun 1, 1980·Clinical Pharmacology and Therapeutics·P J NeuvonenM J Mattila
Nov 1, 1980·British Journal of Clinical Pharmacology·R A Ahmad, H J Rogers

❮ Previous
Next ❯

Citations

Dec 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·N RastogiV Labrousse
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J P SouzaS W Crawford
May 22, 2009·The Journal of Antimicrobial Chemotherapy·Manju Y KrishnanMichael T Collins
Aug 1, 1990·British Journal of Clinical Pharmacology·M D EdsteinJ R Veenendaal
Feb 1, 1991·Antimicrobial Agents and Chemotherapy·F DerouinJ J Pocidalo
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·G A BreenS Forlenza
Feb 5, 2005·Annales de dermatologie et de vénéréologie·E BegonP Wolkenstein
Jan 13, 2001·Dermatologic Clinics·U Paniker, N Levine
Sep 4, 2010·Drug Metabolism and Pharmacokinetics·Motohiro KatoYuichi Sugiyama
Jul 19, 2016·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Marc GhannoumJosée Bouchard
Aug 21, 2001·Journal of the American Academy of Dermatology·Y I Zhu, M J Stiller
Apr 5, 2019·Expert Opinion on Drug Metabolism & Toxicology·Elisa MolinelliAnnamaria Offidani
Jun 10, 2009·Expert Opinion on Pharmacotherapy·Amanda Pickert, Sharon Raimer
Feb 7, 2020·Clinical and Experimental Pediatrics·Keum Hwa LeeJae Il Shin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.